Cytosorbents Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cytosorbents Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Cytosorbents Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.33M, a 74.6% increase year-over-year.
  • Cytosorbents Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$18.7M, a 20.3% increase year-over-year.
  • Cytosorbents Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$28.5M, a 13.1% increase from 2022.
  • Cytosorbents Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$32.8M, a 33.6% decline from 2021.
  • Cytosorbents Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$24.6M, a 213% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$18.7M -$2.33M +$6.86M +74.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$25.5M -$4.14M +$2.01M +32.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$27.5M -$6.36M +$968K +13.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$28.5M -$5.83M -$5.07M -662% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$23.4M -$9.19M +$3.01M +24.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$26.4M -$6.15M +$4.73M +43.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$31.2M -$7.33M +$1.64M +18.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$32.8M -$766K +$8.54M +91.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$41.4M -$12.2M -$5.79M -90.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$35.6M -$10.9M -$6.2M -133% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$29.4M -$8.97M -$4.8M -115% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$24.6M -$9.31M -$8.63M -1273% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$15.9M -$6.41M -$5.57M -663% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$10.4M -$4.68M -$1.81M -63.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$8.55M -$4.17M -$715K -20.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$7.84M -$678K +$3.27M +82.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 -$11.1M -$840K +$6.05M +87.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$17.2M -$2.87M +$680K +19.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$17.8M -$3.45M +$1.43M +29.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$19.3M -$3.95M +$1.45M +26.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$20.7M -$6.89M -$3.88M -129% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$16.8M -$3.55M +$2.27M +39.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$19.1M -$4.88M -$1.9M -63.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$17.2M -$5.4M -$2.26M -71.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 -$15M -$3M -$950K -46.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$14M -$5.82M -$4.09M -236% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$9.92M -$2.98M -$1.46M -95.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$8.46M -$3.15M +$1.59M +33.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$10M -$2.05M +$134K +6.12% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$10.2M -$1.73M +$1.27M +42.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$11.5M -$1.52M +$311K +17% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$11.8M -$4.73M -$1.39M -41.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$10.4M -$2.19M +$659K +23.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$11M -$3.01M -$4.44M -310% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$6.6M -$1.84M +$2.88M +61.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$9.48M -$3.35M +$1.65M +33% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$11.1M -$2.85M -$1.35M -90% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$9.78M $1.43M +$3.29M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$13.1M -$4.72M -$3.74M -384% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$9.32M -$4.99M -$4.33M -646% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$5M -$1.5M -$534K -55.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$4.46M -$1.85M -$439K -31% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$4.02M -$975K +$654K +40.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$4.68M -$669K -$131K -24.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$4.55M -$965K -$313K -48% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$4.23M -$1.41M -$368K -35.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.87M -$1.63M -$202K -14.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$3.66M -$538K +$659K +55.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$4.32M -$652K +$1.08M +62.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$5.4M -$1.05M +$294K +21.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$5.69M -$1.43M -$212K -17.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$5.48M -$1.2M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-31
Q3 2011 -$1.73M -$940K -119% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-21
Q2 2011 -$1.34M -$665K -98.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.21M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$788K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$676K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.